Start with what you may need to act on. Then see what changed in rules, products, and procedures. Every file separates an official action from what it does—and does not—mean for you.
6U.S. files on this edition
1,298,361active cosmetic product listings reported by FDA
PrimaryFDA records open with every claim
September 5, 2026last editorial review
01 / Worth knowing now
Start here if safety brought you in.
These are current FDA communications with a practical next step. The alert scope stays visible so one product or report does not become a blanket claim.
FDA laboratory testing found high mercury levels in La Crema De Rebeca. The agency says repeated skin exposure can cause serious, potentially permanent kidney and neurologic harm.
Keep in mind: The warning letter names one product and company. It does not establish that every skin-lightening product contains mercury, and it is not a recall notice.2 min read →
FDA says it received reports of burns, scarring, fat loss, disfigurement, and nerve damage with certain uses of radiofrequency microneedling devices.
Keep in mind: Adverse-event reports do not show how often complications occur or establish that every device or use has the same risk. FDA says its evaluation is ongoing.2 min read →
02 / What changed
Rules and options, translated.
Administrative data is not a safety grade, and permission is not shelf availability. These files explain the difference before the headline travels.
An October 1 company notice posted by FDA cites potentially elevated endotoxin levels.
Keep in mind: No risk denominator or measured endotoxin values are supplied. The notice does not establish cosmetic use, oral or topical risk, or treatment efficacy.2 min read →
A final U.S. order removes PABA and trolamine salicylate from the sunscreen monograph. FDA says consumers need not change their sunscreen use in response.
Keep in mind: The order covers two sunscreen actives, not all chemical filters. Its scheduled effective date is September 11, 2027, with a statutory exception if disputed.2 min read →
FDA reported 16,398 active facility registrations and 1,298,361 active cosmetic product listings as of June 30, 2026. Listing is a traceability requirement, not FDA approval.
Keep in mind: The totals are administrative data, not safety scores. FDA explicitly says registration and listing are neither cosmetic approval nor a promotional certificate.2 min read →
The FDA issued a final order allowing bemotrizinol at concentrations up to 6%. Product launches still depend on manufacturers and compliant finished formulas.
Keep in mind: Permission is not the same as immediate shelf availability, and it does not make every future formula equally protective or tolerable.2 min read →
03 / The U.S. primer
Four distinctions that prevent a lot of confusion.
Cosmetic listing is not approval.Most cosmetics do not go through FDA premarket approval. Registration and product listing improve traceability but do not certify safety or effectiveness.
Sunscreen is an over-the-counter drug.Its active ingredients and finished labeling follow drug requirements, which is why adding a new U.S. sunscreen filter requires a regulatory order.
A cleared device has a specific use.FDA authorization is tied to a device and indication. It does not validate every treatment claim, setting, body area, or product used with it.
A report is a signal, not an incidence rate.Adverse-event reports can reveal serious problems, but they usually cannot tell you how often an event occurs or prove the cause on their own.
Check it yourself
Official U.S. lookups worth bookmarking
Use these live FDA pages when a brand post, treatment pitch, or old screenshot needs a reality check.
